C69.02
Malignant neoplasm of left conjunctiva
Clinical Classification Guidelines
Medical Intelligence & Overview
Malignant neoplasm of the left conjunctiva, classified under ICD-10 code C69.02, is a type of eye cancer that occurs on the surface of the eye's conjunctiva. The conjunctiva is the thin, transparent tissue covering the front part of the eye and the inner surface of the eyelids. When cancer develops in this area, it can affect vision and eye health if not diagnosed and managed appropriately. This article provides an overview of this condition, including its causes, symptoms, diagnosis, and potential treatment options.
Causes & Symptoms
Clinical Causes: Exposure to ultraviolet (UV) radiation from the sun or artificial sources like welding lamps. Chronic inflammation or irritation of the conjunctiva. Human papillomavirus (HPV) infections. Immunosuppressive conditions or therapy that diminish immune defenses. History of ocular or skin cancers, which may indicate susceptibility. Genetic predispositions in some cases.
Key Symptoms: A persistent or enlarging pigmented or non-pigmented lesion on the conjunctiva. Presence of a raised, crusted, or ulcerated growth near the eye. Color variations in the lesion, including reddish or brownish areas. Discomfort, irritation, or the sensation of a foreign body in the eye. Possible changes in vision if the tumor advances or affects surrounding tissues. In some instances, no noticeable symptoms in early stages.
Diagnostic & Treatment
Diagnosis Path: Detailed slit-lamp examination to assess the lesion's size, color, and characteristics. Photographic documentation of the lesion for monitoring changes over time. Biopsy of the affected tissue to determine the presence and type of malignancy. Imaging studies, such as ocular ultrasound or MRI, to evaluate the extent of tumor invasion. Evaluation for any regional lymph node involvement or metastasis.
Treatment Protocols: Surgical excision of the tumor with clear margins, sometimes involving eyelid or conjunctival reconstruction. Cryotherapy (freezing therapy) applied to the lesion margins to destroy residual cancerous cells. Topical chemotherapy agents, such as mitomycin C or 5-fluorouracil, to treat residual or inoperable tumors. Radiotherapy in cases where surgical removal is not feasible or to address more extensive disease. Targeted therapies or immunotherapy, depending on tumor characteristics and progression.
Clinical Advice & FAQs
Billing Guidance
Is C69.02 a billable ICD-10 code?
Yes, C69.02 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report C69.02?
Clinical documentation must specify the nature of Malignant neoplasm of left conjunctiva and any associated comorbidities for accurate reporting.
Cite this Clinical Reference